Written by Sergi Riudalbàs Clemente | 30th November 2022
The South Korean legislation does not make a clear distinction between hemp and cannabis. This report provides a detailed overview of the regulatory framework in place for hemp, cannabinoids and cannabis, covering all policy areas...
CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries ...
This report offers our analysis of the regulatory regime in South Korea for CBD and related products, including extracts and finished products, their import and export, and medical and recreational cannabis ...
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.